Info
🌱來自: snippets
MYELOMA
Symptomatic multiple myeloma, Ig? lambda/kappa, ISS I-III, Durie-Salmon I-IIIAB
- Initial presentation:
- WOrk up: check LDH, Ca, Alb, B2-microglobulin, sPEP, sIFE, uPEP, uIFE, serum FLC, IgG, IgA, IgM, urine 24hr total protein, skeletal survey, bone marrow study, flowcytometry, cytogenetics, FISH if possible
- Other workup if clinically indicated: MRI, CT scan (avoid contrast), PET/CT, tissue diagnosis if plasmacytoma, staining of marrow and fat pad for amyloid, serum viscosity, HLA typing
- Follow up parameters: PEP, IFE, CBC-DC, Bun, Cr, Ca, bone survey annually or s/s, bone marrow biopsy, sFLC, MRI/PET/CT if indicated.
- Treatment plan: candidate for transplantation: induction with VTD X 4 cycles (Bortezomib 1.3mg/m2 SC on D1,8,15,22, thalidomide 100mg QD, Dexamethasone 20mg D1-2, 8-9, 15-16, 22-23 QW, every 5 weeks) ⇒ auto PBSCT ⇒ consolidation VTD x 4 cycles; adjunt treatment with bisphosphonates
- 2016/00/00 explain purpose of treatment is to cure but not 100%, need long term follow up, and @ myeloma work up: check lab and arrange bone marrow study to send for flowcytometry and chromosome @ apply velcade **explain AEs of treatment, such as peripheral sensory neuropathy, fatigue, emesis, diarrhea, myelosuppression, fever (40%), constipation, increased infection risk, osteoporosis
Siblings
- PANCREATIC_ADJ
- AMPULLA
- ANAL
- APTT
- Comfirmed COVID on ?
- APTTPT
- Adrenal
- BCADJ
- BCADJH
- BCFU
- BCMET
- BMD
- BREASTPE
- Bruising
- CCC
- CHEMOAE
- CRCADJ
- CRCCHEMOAE
- CRCFU
- CRCM
- DTIC
- ESOCA
- ESRD
- EYE
- FL
- GB
- GBM
- GC
- GCA
- GCFU
- GIST
- HBV
- HCC
- HNSCCAE
- HNSCCAECCRT
- HP
- HYPERLIPIDEMIA
- IDA
- INDUCTIONBC
- IO
- ImatinibNIH
- KARNOFSKYPS
- LAP
- LUNGNET
- LUNGNETS
- MEGESTROL
- MYELOMA
- NET
- NSCLC
- NSCLCADJ
- NSCLCFU
- PANCREATIC
- PE
- PEGI
- PGNG
- PLT
- PNET
- RECTALADJ
- RECTALCCRT
- RECTALNET